Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus

Journal of International Medical Research

Volumn 42, Issue 5, 2014, Pages 1123-1130

  Du, Juan ^a   Li, Zongshu ^b   Shi, Jingwei ^a   Bi, Liqi ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Jilin Province People's Hospital   (China)

Author keywords

interleukin 17; interleukin 23; renal disease; serum; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA; PREDNISONE;

ADULT; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84907188637     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513509130     Document Type: Article

References (27)

1. Buckner JH.Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.Nat Rev Immunol. 2010;10:849-859
2. Charles N,Hardwick D,Daugas E, et al.Basophils and the T helper 2 environment can promote the development of lupus nephritis.Nat Med. 2010;16:701-707
3. Vincent FB,Morand EF,Mackay F.BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.Immunol Cell Biol. 2012;90:293-303
4. Park H,Li Z,Yang XO, et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.Nat Immunol. 2005;6:1133-1141
5. Harrington LE,Hatton RD,Mangan PR, et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol. 2005;6:1123-1132
6. Chabaud M,Durand JM,Buchs N, et al.Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.Arthritis Rheum. 1999;42:963-970
7. Kurasawa K,Hirose K,Sano H, et al.Increased interleukin-17 production in patients with systemic sclerosis.Arthritis Rheum. 2000;43:2455-2463
8. Lock C,Hermans G,Pedotti R, et al.Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.Nat Med. 2002;8:500-508
9. Nalbandian A,Crispín JC,Tsokos GC.Interleukin-17 and systemic lupus erythematosus: current concepts.Clin Exp Immunol. 2009;157:209-215
10. Maddur MS,Miossec P,Kaveri SV, et al.Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.Am J Pathol. 2012;181:8-18
11. Korn T,Bettelli E,Oukka M, et al.IL-17 and Th17 Cells.Annu Rev Immunol. 2009;27:485-517
12. Wong CK,Lit LC,Tam LS, et al.Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.Clin Immunol. 2008;127:385-393
13. Huang X,Hua J,Shen N, et al.Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients.Mod Rheumatol. 2007;17:220-223
14. Puwipirom H,Hirankarn N,Sodsai P, et al.Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.Arthritis Res Ther. 2010;12:R215-R215
15. Tan EM,Cohen AS,Fries JF, et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum. 1982;25:1271-1277
16. Ibañez D,Gladman DD,Urowitz MB.Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.J Rheumatol. 2005;32:824-827
17. Balow JE.Clinical presentation and monitoring of lupus nephritis.Lupus. 2005;14:25-30
18. Dimitriou SG,Madaio MPSystemic lupus erythematosus: a companion to rheumatology. Tsokos GCGordon CSmolen J, ed. Philadelphia, PA: Mosby; 2007:287-292.
19. Houssiau FA,Ginzler EM.Current treatment of lupus nephritis.Lupus. 2008;17:426-430
20. Zhang Z,Kyttaris VC,Tsokos GC.The role of IL-23/IL-17 axis in lupus nephritis.J Immunol. 2009;183:3160-3169
21. Lina C,Conghua W,Nan L, et al.Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.J Clin Immunol. 2011;31:596-605
22. Prado C,de Paz B,Gómez J, et al.Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients.Rheumatology (Oxford). 2011;50:1794-1801
23. Ma J,Yu J,Tao X, et al.The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients.Clin Rheumatol. 2010;29:1251-1258
24. Eastaff-Leung N,Mabarrack N,Barbour A, et al.Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.J Clin Immunol. 2010;30:80-89
25. Sousa GM,Oliveira IS,Andrade LJ, et al.Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.Cytokine. 2012;60:138-142
26. Borovcanin M,Jovanovic I,Radosavljevic G, et al.Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.J Psychiatr Res. 2012;46:1421-1426
27. Vincent FB,Northcott M,Hoi A, et al.Clinical associations of serum interleukin-17 in systemic lupus erythematosus.Arthritis Res Ther. 2013;15:R97-R97